19 Matching Annotations
  1. May 2021
    1. doi: 10.1101/2020.05.07.20093963.

      Rosado J, Pelleau S, Cockram C et al. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. The Lancet Microbe 2021; doi: 10.1016/S2666-5247(20)30197-X.

    2. doi: 10.1101/2020.06.05.135921.

      Bertoglio F, Meier D, Langreder N et al. SARS-CoV-2 neutralizing human recombinant antibodies selected from –pre-pandemic healthy donors binding at RBD-ACE2 interface. Nature Communications 2021; doi: 10.1038/s41467-021-21609-2.

    3. doi: 10.1101/2020.07.17.20140533.

      Sahin U, Muik A, Derhovnessian E et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell repsonses. Nature 2020; doi: 10.1038/s41586-020-2814-7.

    4. doi: 10.1101/2020.06.29.178509.

      Tian J-H, Patel N, Haupt R et al. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice. Nature Communications 2021; doi: 10.1038/s41467-020-20653-8.

    5. doi: 10.1101/2020.06.27.175166.

      Routhu NK, Cheedarla N, Gangadhara S et al. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity 2021; doi: 10.1016/j.immuni.2021.02.001.

    6. doi: 10.1101/2020.08.09.242867.

      Gai J, Ma L, Li G et al. A potent neutralizing nanobody against SARS-CoV-2 with inhaled delivery potential. MedComm 2021; doi: 10.1002/mco2.60.

    7. doi: 10.1101/2020.06.22.20137695.

      Hicks J, Klumpp-Thomas C, Kalish H et al. Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses. Journal of Clinical Immunology. 2021. doi: https://doi.org/10.1007/s10875-021-00997-6

    8. doi: 10.1101/2020.07.29.20162917

      Klassan SA, Senefeld, JW, Johnson PW et al. The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysis. medRxiv 2021; doi: 10.1101/2020.07.29.20162917.

    9. doi: 10.1101/2020.04.28.20083139

      Xiao T, Wang Y, Yuan J et al. Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers. Frontiers in Medicine. 2021. doi:https://doi.org/10.3389/fmed.2021.595773

    10. doi: 10.1101/2020.08.21.261909.

      Gontu A, Srinivasan S, Salazar E et al. Limited window for donation of convalescent plasma with high live-virus neutralizing antibodies for COVID-19 immunotherapy. Communications Biology 2021; doi: 10.1038/s42003-021-01813-y.

    11. doi: 10.1101/2020.07.18.20155374.

      Iyer AS, Jones FK, Nodoushania A et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol 2020; doi:10.1126/sciimmunol.abe0367.

  2. Mar 2021
    1. Patricio R Estevez-Soto. (2020, November 24). I’m really surprised to see a lot of academics sharing their working papers/pre-prints from cloud drives (i.e. @Dropbox @googledrive) 🚨Don’t!🚨 Use @socarxiv @SSRN @ZENODO_ORG, @OSFramework, @arxiv (+ other) instead. They offer persisent DOIs and are indexed by Google scholar [Tweet]. @prestevez. https://twitter.com/prestevez/status/1331029547811213316

  3. Oct 2020
    1. and serve as pre-prints to work that may live later on, or always exist in their current format

      Thinking of a personal site as a pre-print server is an interesting concept and somewhat similar to the idea of a commonplace book.

  4. Aug 2020
  5. May 2020
  6. Apr 2020
  7. Jun 2018
  8. Mar 2017
    1. If Kriegeskorte is invited by a journal to write a review, first he decides whether he’s interested enough to review it. If so, he checks whether there’s a preprint available—basically a final draft of the manuscript posted publicly online on one of several preprint servers like arxiv and biorxiv. This is crucial. Writing about a manuscript that he’s received in confidence from a journal editor would break confidentiality—talking about a paper before the authors are ready. If there’s a preprint, great. He reviews the paper, posts to his blog, and also sends the review to the journal editor.

      Interesting workflow and within his rights.